PCM
MDT icon

Prelude Capital Management’s Medtronic MDT Stock Holding History

Prelude Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,500
Closed -$1.3M – 1211
2025
Q1 		$1.3M Buy
+14,500
New +$1.3M 0.1% 249
2020
Q2 		– Sell
-400
Closed -$36K – 2141
2020
Q1 		$36K Buy
+400
New +$42.6K ﹤0.01% 835
2014
Q3 		– Sell
-14,000
Closed -$893K – 2015
2014
Q2 		$893K Buy
+14,000
New +$850K 0.12% 203

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Prelude Capital Management's MDT Position: Q1 2026 in Review

Prelude Capital Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 5,352 shares — an estimated $514K sold.

Prelude Capital Management first reported a position in MDT in Q3 2013 and held it in 27 quarters. The position peaked at $4M in Q1 2024. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Prelude Capital Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 5,352 Medtronic shares in Q1 2026, an estimated $514K.
  • Prelude Capital Management first reported a position in Medtronic in Q3 2013 and held it in 27 quarters.
  • Prelude Capital Management's Medtronic position peaked at $4M in Q1 2024.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.